Incorporating Novel Device Designs, Treatment Strategies and Therapeutic Adjuncts into Mechanical Circulatory Support Therapy

The field of mechanical circulatory support (MCS) has evolved with the long view that an era would eventually emerge in which the complete focus need not be upon rudimentary device reliability or clinical viability, but upon reaching patients to optimize MCS therapy with improved understanding and novel technologies. By most measures, we have arrived in that era. During this conference we will review novel approaches to patient selection for MCS, and strategies to reach underserved patient populations. We will address new therapy optimization and management strategies unconfined by traditional “acute” and “chronic” or “temporary” or “durable” labels, and include the prospects of heart failure recovery or remission. We will uncover the latest clinical insights into the physiology of advanced heart failure during MCS and will review the numerous novel clinical trials highlighting emerging techniques and technologies.